COMMUNIQUÉS West-GlobeNewswire

ORIC® Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Updates
12/08/2025
Reported potentially best-in-class clinical efficacy and safety data from ongoing Phase 1b trial of ORIC-944 in combination with AR inhibitors for the treatment of patients with mCRPC Strengthened cash position with $ [...]
Kyverna Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
12/08/2025
Topline data for registrational Phase 2 trial of KYV-101 in stiff person syndrome (SPS) and BLA submission anticipated in 1H 2026 Registrational Phase 3 KYV-101 trial in myasthenia gravis (MG) to include ~60 patients [...]
Maze Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights
12/08/2025
MZE782 Phase 1 Trial in Healthy Volunteers to Provide Proof of Mechanism Data for Phenylketonuria (PKU) and Chronic Kidney Disease (CKD) Expected in Q3 2025 MZE829 Phase 2 HORIZON Trial Actively Enrolling Patients with [...]
Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
12/08/2025
S econd quarter 2025 revenues were $15.0 million Emrosi™ net sales of $2.8 million generated in first full quarter on the market The Company joined the Russell 2000® and Russell 3000® Indexes in June 2025 Company to [...]
Compass Therapeutics Announces Proposed Public Offering
12/08/2025
BOSTON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat [...]
Erasca Reports Second Quarter 2025 Business Updates and Financial Results
12/08/2025
Efficient execution accelerated clinical entry of pan-RAS molecular glue ERAS-0015 and pan-KRAS inhibitor ERAS-4001 Phase 1 monotherapy data for RAS-targeting franchise expected in 2026 Robust balance sheet with cash, [...]
Editas Medicine Announces Second Quarter 2025 Results and Business Updates
12/08/2025
Company to select lead development candidate in September; on track to file IND by mid-2026 and achieve human proof-of-concept by year-end 2026 First IND/CTA accepted for CD19 HD Allo CAR T program as part of [...]
Verrica Pharmaceuticals Reports Second Quarter 2025 Financial Results
12/08/2025
– Company reports $12.7 million in revenue in Q2’25, consisting primarily of $4.5 million in YCANTH ® revenue, net, reflecting sequential growth of 32.5% over Q1’25 and $8.0 million in milestone revenue from Torii [...]
Nkarta Reports Second Quarter 2025 Financial Results and Corporate Highlights
12/08/2025
Initial update for NKX019 in multiple autoimmune indications expected in second half of 2025 Cash balance of $334.0 million on June 30, 2025, including cash, cash equivalents and investments, expected to fund operations [...]
Lyra Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
12/08/2025
– Positive ENLIGHTEN 2 Phase 3 results announced in June 2025 propel business activities in manufacturing, regulatory strategy and ENLIGHTEN clinical dataset analysis to advance path forward for LYR-210 for treatment of [...]
Fate Therapeutics Reports Second Quarter 2025 Financial Results and Business Updates
12/08/2025
First patient treated with FT819 off-the-shelf CAR T-cell product candidate following fludarabine-free conditioning for severe lupus nephritis demonstrated durability of response with drug-free definition of remission [...]
MedTech Manufacturer Juvent Joins the Inc. 5000 List of America’s Fastest-Growing Private Companies
12/08/2025
With Three-Year Revenue Growth of 552%, This Marks Juvent’s First Time on the List CHATTANOOGA, Tenn., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Inc., the leading media brand and playbook for the entrepreneurs and business [...]
TRYVIO nominated for the 2025 Prix Galien USA “Best Pharmaceutical Product”
12/08/2025
Allschwil, Switzerland – August 12, 2025 Idorsia Ltd (SIX: IDIA) announced today that The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, has nominated TRYVIO™ ( [...]
Birches Health, a leading clinical provider of Gambling Addiction care, expands statewide access to specialized Problem Gambling treatment across Nevada
12/08/2025
LAS VEGAS, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Using funding from the Nevada Division of Public and Behavioral Health (DPBH), Birches Health today launched a groundbreaking program focused on expanding access to evidence- [...]
Compass Health announces completion of first-ever capital campaign to fund state-of-the-art facility for intensive behavioral health services
12/08/2025
The campaign supported the construction of the Marc Healing Center, Phase II of Compass Health’s Broadway Campus Redevelopment EVERETT, Wash., Aug. 12, 2025 (GLOBE NEWSWIRE) -- When Compass Health set out to build a [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 32 - 2025
12/08/2025
Aggregated presentation by day and by market Statement of transactions in own shares from August 4th to August 8th 2025 Name of the issuer Identity code of the issuer (Legal Entity Identifier) Day of the transaction [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 32 - 2025
12/08/2025
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 04 août au 08 août 2025 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
Informations relatives au nombre total de droits de vote et d’actions composant le capital
12/08/2025
Informations relatives au nombre total de droits de vote et d’actions composant le capital Nantes, le 12 août 2025 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement [...]
HealthEx Launches Platform to Empower Patients with Real-time Health Record Access in Collaboration with Industry Leaders
12/08/2025
New platform delivers on CMS vision and industry’s urgent need for end-to-end health data interoperability and a patient-centric healthcare ecosystem HealthEx leads a cross-industry effort with athenahealth, CLEAR, [...]

Pages